Spanish researchers reported in The Journal of Sexual Medicine that penile traction therapy (PTT) is an effective treatment for the acute phase of Peyronie’s disease (PD).
About 55 patients who underwent PTT, a novel penile extender device therapy, were studied for 6 months for acute phase (AP) of Peyronie’s by Juan Martinez-Salamanca, MD, PhD, of the Department of Urology at the Autonomous University of Madrid. These patients were compared with 41 patients in the acute phase of Peyronie’s disease who receive no active treatment.
Mean curvature in patients treated with PTT had decreased from 33° to 15° at 6 months and 13° at 9 months from baseline with a mean decrease of 20°. The proportion of patients unable to achieve penetration decreased from 62% to 20% which shows that erectile function and hardness improved significantly.
PTT was associated with the disappearance of sonographic plaques in 48% of patients treated. Thus, the need for surgery was reduced in 40% of patients who would otherwise have been eligible and the complexity of surgical procedures was further simplified in 1out of 3 patients.
The non-active treatment group had a significant increase in penile deformity, where function and hardness worsened and stretched flaccid penile length had decreased.
“PTT seems an effective treatment for the AP of PD in terms of pain reduction, penile curvature decrease, and improvement in sexual function,” the authors concluded.
For more information about various urological conditions, visit Dr. Bert Vorstman at https://urologyweb.com/exclusive-medical-reports/
Dr. Vorstman also blogs at http://www.urologyweb.com/uro-health-blog/
Contact him directly at bvorstmanmd@gmail.com.